Hit enter to search or ESC to close
PEGUS Research
  • Home
  • Services
    • Consumer Behavior Studies
    • Remote Consumer Studies
    • PMTA and MRTP Research
    • Supporting Research Services
    • In-House Research Facilities
  • About Us
    • Our Team
    • Historic Carpenter Building
  • News
  • Contact Us
    • Client Contact
    • Pharmacist Contact
All Posts By

John Evans

no image added yet.
Uncategorized

Application for First OTC Birth Control Pill in the US

By John Evans | Uncategorized
no image added yet.
Uncategorized

PEGUS Research Embraces and Expands WFH Model

By John Evans | Uncategorized
no image added yet.
Uncategorized

RWE Study Conducted by PEGUS Research Published in Contraception

By John Evans | Uncategorized
no image added yet.
Uncategorized

Sterling IRB Features Pegus Research in Whitepaper Article Titled “PPC and Social Media Patient Recruitment: Strategies for Success”

By John Evans | Uncategorized
no image added yet.
Uncategorized

MHRA Approves Nuromol (Combined Paracetamol and Ibuprofen) for General Sale in UK

By John Evans | Uncategorized
no image added yet.
Uncategorized

FDA Approves “First-in-Class” Nasal Antihistamine (Astepro Allergy) For OTC

By John Evans | Uncategorized
no image added yet.
Uncategorized

Clark Richardson Participates in June 2021 FDA Public Workshop on the OTC Drug Facts Label

By John Evans | Uncategorized
no image added yet.
Uncategorized

PEGUS Announces Even More Enhancements to Its “Decentralized” Research Model

By John Evans | Uncategorized
no image added yet.
Uncategorized

Brandon Henrie Promoted to Vice President – Finance and Strategy

By John Evans | Uncategorized
no image added yet.
Uncategorized

FDA Approves New Combination Pain Reliever (Advil Dual Action) for OTC

By John Evans | Uncategorized
1 2 Next
  • PEGUS logo
  • Address:331 S Rio Grande St, Suite 100
    Salt Lake City, UT 84101
  • Phone:(801) 487-9899
  • Email:info@pegus.com
  • Employment Opportunities:Visit this link

About Us

We are a unique, full-service OTC consumer behavior research organization.  We specialize in the label comprehension, self-selection, and actual use studies that lead to successful OTC approval.  We provide expert, end-to-end support for Drug Facts Label development and testing, including consulting, support for FDA interactions, protocol design, study conduct, site selection and management, monitoring, data management, statistics, medical writing and submission-ready data (CDISC) services.

Recent News

  • Application for First OTC Birth Control Pill in the US July 14, 2022
  • PEGUS Research Embraces and Expands WFH Model June 14, 2022
  • RWE Study Conducted by PEGUS Research Published in Contraception June 14, 2022
  • Sterling IRB Features Pegus Research in Whitepaper Article Titled “PPC and Social Media Patient Recruitment: Strategies for Success” April 12, 2022

Quick Links

  • Home
  • Services
  • About Us
  • Latest News
  • Contact Us

© PEGUS Research 2021. All Rights Reserved. Designed, developed, and hosted by

webaholics.co
View our Website Privacy Policy & Study Privacy Notice

  • Home
  • Services
    • Consumer Behavior Studies
    • Remote Consumer Studies
    • PMTA and MRTP Research
    • Supporting Research Services
    • In-House Research Facilities
  • About Us
    • Our Team
    • Historic Carpenter Building
  • News
  • Contact Us
    • Client Contact
    • Pharmacist Contact
    • PEGUS logo
    • Address:
      331 S Rio Grande St, Suite 100
      Salt Lake City, UT 84101
    • Phone:
      (801) 487-9899
    • Email:
      info@pegus.com